Regulus Names Chief Scientist

Xconomy San Diego — 

San Diego-based Regulus Therapeutics, the developer of mircoRNA therapies, said today it has named Neil Gibson as its new chief scientific officer. Gibson was most recently the chief scientific officer and oncology therapeutics head at Pfizer’s oncology research unit in La Jolla, CA. Gibson replaces Peter Linsley, who left last month to join Bothell, WA-based AVI Biopharma (NASDAQ: AVII).